MedTrace Logo

Efficacy of Tranexamic Acid in Brain Tumor Resections

NCT01655927 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2012-08-02

No results posted yet for this study

Summary

The purpose of this study is to determine whether Tranexamic Acid is effective or not in the reduction of intraoperative bleeding loss in brain tumors resections.

Conditions

Interventions

DRUG

Tranexamic Acid

DRUG

Placebo: Saline

Sponsors & Collaborators

  • Colombian Foundation for Epilepsy and Neurological Disease

    lead OTHER

Principal Investigators

  • Randy O Guerra, MD · Colombian foundation center for epilepsy and neurological disease - FIRE

  • Fredy Diaz, MD · Colombian foundation center for epilepsy and neurological disease -FIRE

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2013-07-31

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01655927 on ClinicalTrials.gov